Moderna, Inc. — Director's Dealing 2021

Aug 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2021-08-19

Reporting Person: Berenson Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-19	Common Stock	G	2700	—	Disposed	20098	Direct

Footnotes

F1: The reported disposition represents a bona fide charitable gift made by the reporting person.